Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2020 Jan 16;39:14. doi: 10.1186/s13046-020-1526-z

Correction to: ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway

Xinmiao Yu 1, Minghao Wang 2,✉, Jingjing Wu 3, Qiang Han 4, Xiupeng Zhang 4
PMCID: PMC6964022  PMID: 31941535

Correction to: J Exp Clin Cancer Res (2019) 38:40

https://doi.org/10.1186/s13046-019-1031-4

In the original publication of this manuscript [1], the author mislabeled the CTL group and ZNF326 group in Fig.2-I,J (MTT result). The revised Fig. 2 is shown below.

Fig. 2.

Fig. 2

Impact of ZNF326 expression on the proliferation and invasiveness of glioma cells in vitro. ZNF326 overexpression significantly enhanced the colony formation (a, b), invasiveness (e, f, magnification-400×), and proliferation (i, j) of U87 and U251 glioma cell lines. Conversely, ZNF326 knockdown significantly inhibited colony formation (c, d), invasiveness (g, h, magnification-400×), and proliferation (k, l) of U87 and U251 glioma cell lines. CTL: control group. Each experiment was performed in triplicate. Columns: mean numbers. Bars: S.D. (*: P < 0.05; **: P < 0.01; ***: P < 0.001)

The authors sincerely apologize for the inconvenience caused to the readers.

Reference

  • 1.Yu X, et al. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway. J Exp Clin Cancer Res. 2019;38:40. doi: 10.1186/s13046-019-1031-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES